M&A Deal Summary |
|
|---|---|
| Date | 2011-01-01 |
| Target | CrediQ S.A. de C.V. |
| Sector | Financial Services |
| Buyer(s) | ALTRA Investments |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2005 |
| PE ASSETS | 547M USD |
| Size | Middle-Market |
| Type | Sector Agnostic |
ALTRA Investments is a private equity firm focused on investment opportunities in Columbia and Peru. The firm focuses on midcap companies generating sales of $15 to $150 million. ALTRA generally favors industries with significant barriers to entry, increasing foreign investment, and consolidation possibilities. The firm invests in the range of $30 - $60 million per transactions. ALTRA will not invest in early stage situations, mining exploration, and basic manufacturing without sustainable advantages. ALTRA was formed in 2005 and has offices in Lima and Bogota.
| DEAL STATS | # |
|---|---|
| Overall | 9 of 18 |
| Sector: Financial Services M&A | 1 of 1 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 8 of 17 |
| Country: El Salvador M&A | 1 of 1 |
| Year: 2011 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-10-01 |
TermoYopal
Bogota, Colombia TermoYopal is a strategically located gas-thermal power generation company in Colombia with five energy generation turbines and installed capacity of 109 MW. TermoYopal’s facilities are adjacent to three gas fields with reserves of 1.2 trillion cubic feet, representing 30 years of production at normal rates. TermoYopal is based in Bogota, Colombia. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-01-26 |
Corporación Infarmasa SA
Lima, Peru Corporación Infarmasa SA manufactures and markets branded and unbranded generic drugs, primarily corticosteroids, antihistamines, analgesics and antibiotics, and has of over 600 registered products, of which over 500 are currently marketed. |
Sell | - |
